Randomized trial · people

Tirzepatide: 20.2% weight loss vs 13.7% on semaglutide at 72 weeks

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In a direct head-to-head trial, tirzepatide led to more weight and waist loss than semaglutide over 72 weeks, and gut-related side effects were the most common in both groups.

Kind
Randomized trial
Studied in
People
Number studied
751
Published
2025
Journal
N Engl J Med

What they tested

The team tested whether tirzepatide or semaglutide led to more weight loss in adults with obesity who did not have type 2 diabetes.

How the study was done

A phase 3b, randomized, open-label trial in 751 adults with obesity but without type 2 diabetes. Each person was assigned to the highest dose they could tolerate of either tirzepatide (10 mg or 15 mg) or semaglutide (1.7 mg or 2.4 mg), injected under the skin once a week for 72 weeks.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

Model. Individual results vary.

PepVault for iPhone

Taking tirzepatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

At week 72, body weight changed by an average of -20.2% on tirzepatide and -13.7% on semaglutide (P<0.001). Waist size shrank by 18.4 cm on tirzepatide and 13.0 cm on semaglutide (P<0.001). People on tirzepatide were more likely to lose at least 10%, 15%, 20% and 25% of their weight. In both groups the most common side effects were gut-related, mostly mild to moderate, and they came mainly while doses were being raised.

What it doesn’t show

It was an open-label trial rather than a blinded one, and it was funded by Eli Lilly. It included only adults without type 2 diabetes, so it does not show how the two drugs compare in people with diabetes.

The paper

Aronne et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. N Engl J Med. 2025.

The compounds

More studies on Tirzepatide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking tirzepatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo